Journal of Virus Eradication (Sep 2017)
O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
- Michaela Madlenakova,
- Prakash Shankaran,
- Vera Hajkova,
- David Jilich,
- Ladislav Machala,
- Pavel Martasek,
- Zora Melkova
Affiliations
- Michaela Madlenakova
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Prakash Shankaran
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Vera Hajkova
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- David Jilich
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Ladislav Machala
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Pavel Martasek
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Zora Melkova
- Department of Immunology and Microbiology, Charles University, 1st Faculty of Medicine, Prague, Czech Republic; BIOCEV, Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University, Vestec, Czech Republic; AIDS Center, Na Bulovce Hospital, Prague, Czech Republic
- Journal volume & issue
-
Vol. 3
p. 1
